Drug transport across the placenta

Current Pharmaceutical Biotechnology

Volumn 12, Issue 5, 2011, Pages 707-714

  Eshkoli, Tamar ^a   Sheiner, Eyal ^a   Ben Zvi, Zvi ^b   Feinstein, Valeria ^b   Holcberg, Gershon ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Breast cancer resistance protein mitoxantrone resistance protein; Monoamine transporters; Multidrug resistance associated protein; Organic anion transporters; P glycoprotein

Indexed keywords

ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; BREAST CANCER RESISTANCE PROTEIN; CARDIAC AGENT; CORTICOSTERONE; CYCLOSPORIN A; DEXAMETHASONE; DIGOXIN; DOXORUBICIN; ETOPOSIDE; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; MEVINOLIN; MONOAMINE DERIVATIVE; MULTIDRUG RESISTANCE PROTEIN 2; NEUROLEPTIC AGENT; NORADRENALIN TRANSPORTER; ORGANIC ANION TRANSPORTER; PACLITAXEL; PROTEINASE INHIBITOR; QUETIAPINE; QUINIDINE; RITONAVIR; SAQUINAVIR; SEROTONIN TRANSPORTER; SIMVASTATIN; STEROID; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE;

DRUG SOLUBILITY; DRUG TRANSPORT; HUMAN; LIPID SOLUBILITY; PLACENTAL TRANSFER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SYNCYTIOTROPHOBLAST;

EID: 79955627123     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111795470877     Document Type: Review

References (84)

1. Sastry, B.V. Techniques to study human placental transport. Adv. Drug Deliv. Rev., 1999; 38(1), 17-39.
2. Ganapathy, V.V.; Prasad, P.D.; Ganapathy, M.E.; Leibach, F.H. Drugs of abuse and placental transport. Adv. Drug Deliv. Rev., 1999, 38(1), 99-110.
3. Audus, K.L. Controlling drug delivery across the placenta. Eur. J. Pharm. Sci., 1999, 8(3), 161-165.
4. Ringler, G.E.; Strauss, J.F. 3rd. In vitro systems for the study of human placental endocrine function. Endocr. Rev., 1990, 11(1), 105-123.
5. Ganapathy, V.; Prasad, P.D.; Ganapathy, M.E.; Leibach, F.H. Placental transporters relevant to drug distribution across the maternalfetal interface. J. Pharmacol. Exp. Ther., 2000, 294(2), 413-420.
6. Bourget, P.; Roulot, C.; Fernandez, H. Models for placental transfer studies of drugs. Clin. Pharmacokinet., 1995, 28(2), 161-180.
7. Enders, A.C.; Blankenship, T.N. Comparative placental structure. Adv. Drug Deliv. Rev., 1999, 38(1), 3-15.
8. Jauniaux, E.; Gulbis, B. In vivo investigation of placental transfer early in human pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol., 2000, 92(1), 45-49.
9. St-Pierre, M.V.; Serrano, M.A.; Macias, R.I.; Dubs, U.; Hoechli, M.; Lauper, U.; Meier, P.I.; Marin, J.J. Expression of members of the multidrug resistance protein family in human term placenta. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2000, 279(4), R1495-R1503.
10. Juliano, R.L.; Ling, V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta, 1976, 455(1), 152-162.
11. Rocchi, E.; Khodjakov, A.; Volk, E.L.; Yang, C.H.; Litman, T.; Bates, S.E.; Schneider, E. The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane. Biochem. Biophys. Res. Commun., 2000, 271(1), 42-46.
12. Doyle, L.A.; Ross, D.D. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene, 2003, 22(47), 7340-7358.
13. Leslie, E.M.; Deeley, R.G.; Cole, S.P. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol. Appl. Pharmacol., 2005, 204(3), 216-237.
14. Tanabe, M.; Ieiri, I.; Nagata, N.; Inoue, K.; Ito, S.; Kanamori, Y.; Takahashi, M.; Kurata, Y.; Kigawa, J.; Higuchi, S.; Terakawa, N.; Otsubo, K. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J. Pharmacol. Exp. Ther., 2001, 297(3), 1137-1143.
15. Schinkel, A.H.; Jonker, J.W. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev., 2003, 55(1), 3-29.
16. Evseenko, D.A.; Paxton, J.W.; Keelan, J.A. Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors. Drug Metab. Dispos., 2007, 35(4), 595-601.
17. Sun, M.; Kingdom, J.; Baczyk, D.; Lye, S.J.; Matthews, S.G.; Gibb, W. Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta, 2006, 27(6-7), 602-609.
18. Mathias, A.A.; Hitti,.J.; Unadkat, J.D. P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am. J. Physiol. Regul. Inter. Comp. Physiol., 2005, 289(4), R963-R969.
19. Oude Elferink, R.P.; Paulusma, C.C. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Pflugers Arch., 2007, 453(5), 601-610.
20. Ceckova-Novotna, M.; Pavek, P.; Staud, F. P-glycoprotein in the placenta: expression, localization, regulation and function. Reprod. Toxicol., 2006, 22(3), 400-410.
21. Mölsä, M.; Heikkinen, T.; Hakkola, J.; Hakala, K.; Wallerman, O.; Wadelius, M.; Wadelius, C.; Laine, K. Functional role of Pglycoprotein in the human blood-placental barrier. Clin. Pharmacol. Ther., 2005, 78(2), 123-131.
22. Rahi, M.; Heikkinen, T.; Härtter, S.; Hakkola, J.; Hakala, K.; Wallerman, O.; Wadelius, M.; Wadelius, C.; Laine, K. Placental transfer of quetiapine in relation to P-glycoprotein activity. J. Psychopharmacol., 2007, 21(7), 751-756.
23. Holtzman, C.W.; Wiggins, B.S.; Spinler, S.A. Role of Pglycoprotein in statin drug interactions. Pharmacotherapy, 2006, 26(11), 1601-1607.
24. Drach, J.; Gsur, A.; Hamilton, G.; Zhao, S.; Angerler, J.; Fiegl, M.; Zojer, N.; Raderer, M.; Haberl, I.; Andreeff, M.; Huber, H. Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Blood, 1996, 88(5), 1747-1754.
25. Fardel, O.; Lecureur, V.; Guillouzo, A. The P-glycoprotein multidrug transporter. Gen. Pharmacol., 1996, 27(8), 1283-1291.
26. Huisman, M.T.; Smit, J.W.; Schinkel, A.H. Significance of Pglycoprotein for the pharmacology and clinical use of HIV protease inhibitors. AIDS, 2000, 14(13), 237-242.
27. Mayer, U.; Wagenaar, E.; Dorobek, B.; Beijnen, J.H.; Borst, P.; Schinkel, A.H. Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833. J. Clin. Invest., 1997, 100(10), 2430-2436.
28. Sharom, F.J.; Liu, R.; Romsicki, Y.; Lu, P. Insights into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies. Biochim. Biophys. Acta, 1999, 1461(12), 327-345.
29. Yumoto, R.; Murakami, T.; Nakamoto, Y.; Hasegawa, R.; Nagai, J.; Takano, M. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds. J. Pharmacol. Exp. Ther., 1999, 289(1), 149-155.
30. Wang, J.S.; Newport, D.J.; Stowe, Z.N.; Donovan, J.L.; Pennell, P.B.; DeVane, C.L. The emerging importance of transporter proteins in the psychopharmacological treatment of the pregnant patient. Drug Metab. Rev., 2007, 39(4), 723-746.
31. Zhou, S.F. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica, 2008, 38(7-8), 802-832.
32. Hoffmeyer, S.; Burk, O.; von Richter, O.; Arnold, H.P.; Brockmöller, J.; Johne, A.; Cascorbi, I.; Gerloff, T.; Roots, I.; Eichelbaum, M.; Brinkmann, U. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. USA, 2000, 97(7), 3473-3478.
33. Nakamura, T.; Sakaeda, T.; Horinouchi, M.; Tamura, T.; Aoyama, N.; Shirakawa, T.; Matsuo, O.; Kasuga, M.; Okumura, K. Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin. Pharmacol. Ther., 2002, 71(4), 297-303.
34. Sakaeda, T.; Nakamura, T.; Okumura, K. MDR1 genotype-related pharmacokinetics and pharmacodynamics. Biol. Pharm. Bull., 2002, 25(11), 1391-1400.
35. Kim, R.B.; Leake, B.F.; Choo, E.F.; Dresser, G.K.; Kubba, S.V.; Schwarz, U.I.; Taylor, A.; Xie, H.G.; McKinsey, J.; Zhou, S.; Lan, L.B.; Schuetz, J.D.; Schuetz, E.G.; Wilkinson, G.R. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin. Pharmacol. Ther., 2001, 70(2), 189-199.
36. Hitzl, M.; Schaeffeler, E.; Hocher, B.; Slowinski, T.; Halle, H.; Eichelbaum, M.; Kaufmann, P.; Fritz, P.; Fromm, M.F.; Schwab, M. Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1). Pharmacogenetics, 2004, 14(5), 309-318.
37. Takane, H.; Kobayashi, D.; Hirota, T.; Kigawa, J.; Terakawa, N.; Otsubo, K.; Ieiri, I. Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene. J. Pharmacol. Exp. Ther., 2004, 311(3), 1179-1187.
38. Doyle, L.A.; Yang, W.; Abruzzo, L.V.; Krogmann, T.; Gao, Y.; Rishi, A.K. Ross, D.D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA, 1998, 95(26), 15665-15670.
39. Miyake, K.; Mickley, L.; Litman, T.; Zhan, Z.; Robey, R.; Cristensen, B.; Brangi, M.; Greenberger, L.; Dean, M.; Fojo, T.; Bates, S.E. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res., 1999, 59(1), 8-13.
40. Litman, T.; Brangi, M.; Hudson, E.; Fetsch, P.; Abati, A.; Ross, D.D.; Miyake, K.; Resau, J.H.; Bates, S.E. The multidrug-resistant phenotype associated with overexpression of the new ABC halftransporter, MXR (ABCG2). J. Cell Sci., 2000, 113(Pt 11), 2011-2021.
41. Xu, J.; Liu, Y.; Yang, Y.; Bates, S.; Zhang, J.T. Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2. J. Biol. Chem., 2004, 279(19), 19781-19789.
42. Maliepaard, M.; Scheffer, G.L.; Faneyte, I.F.; van Gastelen, M.A.; Pijnenborg, A.C.; Schinkel, A.H.; van De Vijver, M.J.; Scheper, R.J.; Schellens, J.H. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res., 2001, 61(8), 3458-3464.
43. Ceckova, M.; Libra, A.; Pavek, P.; Nachtigal, P.; Brabec, M.; Fuchs, R.; Staud, F. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo. Clin. Exp. Pharmacol. Physiol., 2006, 33(1-2), 58-65.
44. Vähäkangas, K.; Myllynen, P. Drug transporters in the human blood-placental barrier. Br. J. Pharmacol., 2009, 158(3), 665-678.
45. Mao, Q. BCRP/ABCG2 in the placenta: expression, function and regulation. Pharm. Res., 2008, 25(6), 1244-1255.
46. Feinshtein, V.; Holcberg, G.; Amash, A.; Erez, N.; Rubin, M.; Sheiner, E.; Polachek, H.; Ben-Zvi, Z. Nitrofurantoin transport by placental choriocarcinoma JAr cells: involvement of BCRP, OATP2B1 and other MDR transporters. Arch. Gynecol. Obstet., 2010, 281(6), 1037-1044.
47. Gedeon, C.; Anger, G.; Piquette-Miller, M.; Koren, G. Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta. Placenta, 2008, 29(1), 39-43.
48. Pollex, E.; Lubetsky, A.; Koren, G. The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta. Placenta, 2008, 29(8), 743-747.
49. Myllynen, P.; Kummu, M.; Kangas, T.; Ilves, M.; Immonen, E.; Rysä, J.; Pirilä, R.; Lastumäki, A.; Vähäkangas, K.H. ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta. Toxicol. Appl. Pharmacol., 2008, 232(2), 210-217.
50. Kobayashi, D.; Ieiri, I.; Hirota, T.; Takane, H.; Maegawa, S.; Kigawa, J.; Suzuki, H.; Nanba, E.; Oshimura, M.; Terakawa, N.; Otsubo, K.; Mine, K.; Sugiyama, Y. Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug Metab. Dispos., 2005, 33(1), 94-101.
51. Meyer zu Schwabedissen, H.E.; Grube, M.; Dreisbach, A.; Jedlitschky, G.; Meissner, K.; Linnemann, K.; Fusch, C.; Ritter, C.A.; Völker, U.; Kroemer, H.K. Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP). Drug Metab. Dispos., 2006, 34(4), 524-533.
52. Yeboah, D.; Sun, M.; Kingdom, J.; Baczyk, D.; Lye, S.J.; Matthews, S.G.; Gibb, W. Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can. J. Physiol. Pharmacol., 2006, 84(12), 1251-1258.
53. Borst, P.; Evers, R.; Kool, M.; Wijnholds, J. The multidrug resistance protein family. Biochim. Biophys. Acta, 1999, 1461(2), 347-357.
54. Cole, S.P.; Deeley, R.G. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. Bioessays, 1998, 20(11), 931-940.
55. Atkinson, D.E.; Greenwood, S.L.; Sibley, C.P.; Glazier, J.D.; Fairbairn, L.J. Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer. Am. J. Physiol. Cell Physiol., 2003, 285(3), C584-C591.
56. Nagashige, M.; Ushigome, F.; Koyabu, N.; Hirata, K.; Kawabuchi, M.; Hirakawa, T.; Satoh, S.; Tsukimori, K.; Nakano, H.; Uchiumi, T.; Kuwano, M.; Ohtani, H.; Sawada, Y. Basal membrane localization of MRP1 in human placental trophoblast. Placenta, 2003, 24(10), 951-958.
57. Meyer zu Schwabedissen, H.E.; Jedlitschky, G.; Gratz, M.; Haenisch, S.; Linnemann, K.; Fusch, C.; Cascorbi, I.; Kroemer, H.K. Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation. Drug Metab. Dispos., 2005, 33(7), 896-904.
58. Meyer Zu Schwabedissen, H.E.; Grube, M.; Heydrich, B.; Linnemann, K.; Fusch, C.; Kroemer, H.K.; Jedlitschky, G. Expression, localization, and function of MRP5 (ABCC5), a transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts: effects of gestational age and cellular differentiation. Am. J. Pathol., 2005, 166(1), 39-48.
59. Nishimura, M.; Naito, S. Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metab. Pharmacokinet., 2005, 20(6), 452-477.
60. Deeley, R.G.; Cole, S.P. Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett., 2006, 580(4), 1103-1111.
61. Grant, C.E.; Gao, M.; DeGorter, M.K.; Cole, S.P.; Deeley, R.G. Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3). Drug Metab. Dispos., 2008, 36(12), 2571-2581.
62. May, K.; Minarikova, V.; Linnemann, K.; Zygmunt, M.; Kroemer, H.K.; Fusch, C.; Siegmund, W. Role of the multidrug transporter proteins ABCB1 and ABCC2 in the diaplacental transport of talinolol in the term human placenta. Drug Metab. Dispos., 2008, 36(4), 740-744.
63. Anzai, N.; Kanai, Y.; Endou, H. Organic anion transporter family: current knowledge. J. Pharmacol. Sci., 2006, 100(5), 411-426.
64. Sekine, T.; Cha, S.H.; Endou, H. The multispecific organic anion transporter (OAT) family. Pflugers Arch., 2000, 440(3), 337-350.
65. Rizwan, A.N.; Burckhardt, G. Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles. Pharm. Res., 2007, 24(3), 450-470.
66. Ugele, B.; St-Pierre, M.V.; Pihusch, M.; Bahn, A.; Hantschmann, P. Characterization and identification of steroid sulfate transporters of human placenta. Am. J. Physiol. Endocrinol. Metab., 2003, 284(2), E390-E398.
67. Ugele, B.; Bahn, A.; Rex-Haffner, M. Functional differences in steroid sulfate uptake of organic anion transporter 4 (OAT4) and organic anion transporting polypeptide 2B1 (OATP2B1) in human placenta. J. Steroid Biochem. Mol. Biol., 2008, 111(1-2), 1-6.
68. Cha, S.H.; Sekine, T.; Kusuhara, H.; Yu, E.; Kim, J.Y.; Kim, D.K.; Sugiyama, Y.; Kanai, Y.; Endou, H. Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J. Biol. Chem., 2000, 275(6), 4507-4512.
69. St-Pierre, M.V.; Hagenbuch, B.; Ugele, B.; Meier, P.J.; Stallmach, T. Characterization of an organic anion-transporting polypeptide (OATP-B) in human placenta. J. Clin. Endocrinol. Metab., 2002, 87(4), 1856-1863.
70. Sato, K.; Sugawara, J.; Sato, T.; Mizutamari, H.; Suzuki, T.; Ito, A.; Mikkaichi, T.; Onogawa, T.; Tanemoto, M.; Unno, M.; Abe, T.; Okamura, K. Expression of organic anion transporting polypeptide E (OATP-E) in human placenta. Placenta, 2003, 24(2-3), 144-148.
71. Briz, O.; Serrano, M.A.; Maclas, R.I.; Gonzalez-Gallego, J.; Marin, J.J. Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin. Biochem. J., 2003, 371(Pt 3), 897-905.
72. Geyer, J.; Döring, B.; Meerkamp, K.; Ugele, B.; Bakhiya, N.; Fernandes, C.F.; Godoy, J.R.; Glatt, H.; Petzinger, E. Cloning and functional characterization of human sodium-dependent organic anion transporter (SLC10A6). J. Biol. Chem., 2007, 282(27), 19728-19741.
73. Hansson, S.R.; Bottalico, B.; Noskova, V.; Casslén, B. Monoamine transporters in human endometrium and decidua. Hum. Reprod. Update, 2009, 15(2), 249-260.
74. Koepsell, H.; Lips, K.; Volk, C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm. Res., 2007, 24(7), 1227-1251.
75. Gründemann, D.; Gorboulev, V.; Gambaryan, S.; Veyhl, M.; Koepsell, H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature, 1994, 372(6506), 549-552.
76. Sata, R.; Ohtani, H.; Tsujimoto, M.; Murakami, H.; Koyabu, N.; Nakamura, T.; Uchiumi, T.; Kuwano, M.; Nagata, H.; Tsukimori, K.; Nakano, H.; Sawada, Y. Functional analysis of organic cation transporter 3 expressed in human placenta. J. Pharmacol. Exp. Ther., 2005, 315(2), 888-895.
77. Grube, M.; Schwabedissen, H.M.; Draber, K.; Präger, D.; Möritz, K.U.; Linnemann, K.; Fusch, C.; Jedlitschky, G.; Kroemer, H.K. Expression, localization, and function of the carnitine transporter octn2 (slc22a5) in human placenta. Drug Metab. Dispos., 2005, 33(1), 31-37.
78. Wessler, I.; Roth, E.; Deutsch, C.; Brockerhoff, P.; Bittinger, F.; Kirkpatrick, C.J. Kilbinger, H. Release of non-neuronal acetylcholine from the isolated human placenta is mediated by organic cation transporters. Br. J. Pharmacol., 2001, 134(5), 951-956.
79. Kekuda, R.; Prasad, P.D.; Wu, X.; Wang, H.; Fei, Y.J.; Leibach, F.H.; Ganapathy, V. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J. Biol. Chem., 1998, 273(26), 15971-15979.
80. Bottalico, B.; Larsson, I.; Brodszki, J.; Hernandez-Andrade, E.; Casslén, B.; Marsál, K.; Hansson, S.R. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies. Placenta, 2004, 25(6), 518-529.
81. Ahmed, B.A.; Jeffus, B.C.; Bukhari, S.I.; Harney, J.T.; Unal, R.; Lupashin, V.V.; van der Sluijs, P.; Kilic, F. Serotonin transamidates Rab4 and facilitates its binding to the C terminus of serotonin transporter. J. Biol. Chem., 2008, 283(14), 9388-9398.
82. Kekuda, R.; Leibach, F.H.; Furesz, T.C.; Smith, C.H.; Ganapathy, V. Polarized distribution of interleukin-1 receptors and their role in regulation of serotonin transporter in placenta. J. Pharmacol. Exp. Ther., 2000, 292(3), 1032-1041.
83. Unal, R.; Ahmed, B.A.; Jeffus, B.C.; Harney, J.T.; Lyle, C.S.; Wu, Y.K.; Chambers, T.C.; Reece, E.A.; Kilic, F. At diabetes-like concentration, glucose down-regulates the placental serotonin transport system in a cell-cycle-dependent manner. J. Neurochem., 2007, 101(4), 937-948.
84. Ramamoorthy, J.D.; Ramamoorthy, S.; Leibach, F.H.; Ganapathy, V. Human placental monoamine transporters as targets for amphetamines. Am. J. Obstet. Gynecol., 1995, 173(6), 1782-1787.